Amee M. Bigelow

Amee M. Bigelow

Auto-generated profile, based on publicly available information

Amee M. Bigelow

The Heart Center, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH, 43205, USA.

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 June 2023 in The Journal of ExtraCorporeal Technology
Verified
Journal Article
Open access
PDF file
ANAymen N. Naguib
Aymen N. Naguib
SCSergio A. Carrillo
Sergio A. Carrillo
MCMarco Corridore
Marco Corridore
ABAmee M. Bigelow
Amee M. Bigelow
AWAshley B Walczak
Ashley B Walczak
JTJoseph Tobias
Joseph Tobias
Background: Neonates and infants undergoing cardiac surgery tend to receive high volumes of blood products. The use of rotational thromboelastometry (ROTEM®) has been shown to reduce the administration of blood products in adults after cardiac surgery. We sought to develop a targeted administration of blood products based on ROTEM®to reduce blood product utilization during and after neonatal and infant cardiac surgery.Methods: We conducted a retrospective review of data from a single center for neonates and infants undergoing congenital cardiac surgery using cardiopulmonary bypass (CPB) from September 2018-April 2019 (control group). Then, using a ROTEM®algorithm, we collected data prospectively between April-November 2021 (ROTEM group). Data collected included age, weight, gender, procedure, STAT score, CPB time, aortic cross-clamp time, volume, and type of blood products administered in the operating room and cardiothoracic intensive care unit (CTICU). In addition, ROTEM®data, coagulation profile in CTICU, chest tube output at 6 and 24 hours, use of factors concentrate, and thromboembolic complications were recorded.Results: The final cohort of patients included 28 patients in the control group and 40 patients in the ROTEM group. The cohort included neonates and infants undergoing the following procedures: arterial switch, aortic arch augmentation, Norwood procedure, and comprehensive stage II procedure. There were no differences in the demographics or procedure complexity between the two groups. Patients in the ROTEM®group received fewer platelets (36 ± 12 vs. 49 ± 27 mL/kg, p 0.028) and cryoprecipitate (8 ± 3 vs. 15 ± 10 mL/kg, p 0.001) intraoperatively when compared to the control group.Conclusion: The utilization of ROTEM®may have contributed to a significant reduction in some blood product administration during cardiac surgery for infants and neonates. ROTEM®data may play a role in reducing blood product administration in neonatal and infant cardiac surgery.

27 October 2016 in Pediatrics
Verified
Journal Article
Open access
PDF file
ABAmee M. Bigelow
Amee M. Bigelow
JSJohn P. Scott
John P. Scott
JHJohnny C. Hong
Johnny C. Hong
DCDavid C. Cronin
David C. Cronin
BVBernadette E. Vitola
Bernadette E. Vitola
TPTara L. Petersen
Tara L. Petersen
Among infants, almost half of acute liver failure cases are classified as indeterminate, whereas only a small number of cases show a documented viral infection. We present the first reported case of isolated acute hepatic failure in an infant in the setting of a human parechovirus (HPeV) infection. HPeV also may have been contributory to the posttransplant complication of 2 intussusceptions. This is a 10-month-old girl who presented with only symptoms of fussiness and was noted to have progressive decline in synthetic liver function as well as worsening coagulopathy requiring a liver transplant. The acute liver failure was in the setting of a positive serum RNA HPeV, subtype 3 (HPeV-3), after extensive diagnostic testing with genetic, autoimmune, and infectious causes otherwise negative. After liver transplantation, the postoperative course was complicated by both an ileal-ileal intussusception as well as a jejunal intussusception. Viral testing in pediatric acute liver failure is often performed, but the workup is frequently incomplete. This case report would support more extensive viral testing in this population of patients. In the setting of HPeV, clinicians could be alerted to the possibility of delayed gastrointestinal pathology in the posttransplant phase. Wider use of routine HPeV testing may more clearly define the variable clinical presentations and outcomes.

2 December 2016 in EP Europace
Verified
Journal Article
Closed access
PDF file
ABAmee M. Bigelow
Amee M. Bigelow
PSPhilip C. Smith
Philip C. Smith
DTDylan T. Timberlake
Dylan T. Timberlake
NMNeil L. McNinch
Neil L. McNinch
GSGrace L. Smith
Grace L. Smith
JCJohn M. Clark
John M. Clark
Non-fluoroscopic catheter ablation is becoming routine. In experienced centres, fluoroscopy is rarely required. The use of a traditional catheterization lab (cath lab) may no longer be necessary. We began performing catheter ablations at a paediatric centre outside the traditional cardiac cath lab in 2013. The purpose of this study was to compare procedural features of paediatric catheter ablation performed outside the cath lab to those performed within a cath lab. We prospectively looked at patients presenting to the paediatric centre with supraventricular tachycardia (SVT) undergoing catheter ablation outside the cath lab in a standard operating room (OR group). We compared retrospectively to a control group matched for age, type, and location of arrhythmia who had ablations in a traditional cath lab (CL group). Catheter visualization was exclusively by electro-anatomic mapping. Fifty-nine patients with SVT underwent catheter ablation in the OR from October 2013 to December 2015. Thirty-three patients had accessory pathways, 29 were manifest, and 13 of those were left sided. Twenty-six had atrioventricular nodal re-entrant tachycardia. Transseptal puncture with transoesophageal echocardiography guidance was used for 10 left-sided pathways, whereas the other 3 had patent foramen ovales. Procedure time did not differ significantly between groups (OR group mean 131 min, range 57–408; CL group mean 152 min, range 68–376; P = 0.12). Acute success was similar in both groups [OR group: 58/59 (98.3%) and CL group: 57/59 (96.6%)]. There were no major complications in either group. There was no fluoroscopy used in either group. Although performing paediatric catheter ablations outside the traditional cath lab is early in our experience, we produced similar outcomes and results without encountering procedural difficulties of performing ablations in a non-conventional setting. Larger multi-centred trials will be essential to determine the feasibility of this practice.

21 October 2016 in Cardiology in the Young
Verified
Journal Article
Closed access
PDF file
ABAmee M. Bigelow
Amee M. Bigelow
BABrandon S. Arnold
Brandon S. Arnold
GPGregory C. Padrutt
Gregory C. Padrutt
JCJohn M. Clark
John M. Clark
In current practice, children with anatomically normal hearts routinely undergo fluoroscopy-free ablations. Infants and children with congenital heart disease (CHD) represent the most difficult population to perform catheter ablation without fluoroscopy. We report two neonatal patients with CHD in whom cardiac ablations were performed without fluoroscopy. The first infant had pulmonary atresia with intact ventricular septum with refractory supraventricular tachycardia, and the second infant presented with Ebstein’s anomaly of the tricuspid valve along with persistent supraventricular tachycardia. Both patients underwent uncomplicated, successful ablation without recurrence of arrhythmias. These cases suggest that current approaches to minimising fluoroscopy may be useful even in challenging patients such as neonates with CHD.

21 April 2023 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
ABAmee M. Bigelow
Amee M. Bigelow
KRKyle W. Riggs
Kyle W. Riggs
DMDavid L. S. Morales
David L. S. Morales
AOAlexander R. Opotowsky
Alexander R. Opotowsky
ALAdam M. Lubert
Adam M. Lubert
TATarek Alsaied
Tarek Alsaied

1 July 2015 in Heart Rhythm
Verified
Journal Article
Closed access
ABAmee M. Bigelow
Amee M. Bigelow
MKMohamed Khalifa
Mohamed Khalifa
JCJohn M. Clark
John M. Clark